Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
As of today, Bristol-Myers Squibb(BMY) shares are valued at $63.35. The company's market cap stands at 134.94B, with a P/E ratio of 16.98 and a dividend yield of 4.13%.
On 2026-07-29, Bristol-Myers Squibb(BMY) stock traded between a low of $63.10 and a high of $63.91. Shares are currently priced at $63.35, which is +0.4% above the low and -0.9% below the high.
Bristol-Myers Squibb(BMY) shares are trading with a volume of 10.61M, against a daily average of 10.48M.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $64.97 and a 52-week low of $42.52.
In the last year, Bristol-Myers Squibb(BMY) shares hit a 52-week high of $64.97 and a 52-week low of $42.52.
BMY News
Bristol-Myers Squibb (BMY) is projected to report a nearly 10% jump in its Q2 earnings when it reports its results on July 29, after the closing bell. Wall Str...
Analysts expect the company to report quarterly earnings of $1.60 per share, up from $1.46 per share in the year-ago period. The consensus estimate for Bristol-...
Bristol-Myers Squibb stock has delivered a strong 42.2% return over the past year, while the current valuation checks show a mixed picture and the Discounted Ca...
Analyst ratings
61%
of 31 ratingsMore BMY News
Artificial intelligence (AI) is changing every industry, and even companies outside the technology sector are partnering with Nvidia (NVDA +0.28%), one of the l...
BMO Capital analyst Evan Seigerman has reiterated their neutral stance on BMY stock, giving a Hold rating on July 24. Unlock powerful investing tools with TipR...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter,...
With markets on edge over aggressive AI spending by Alphabet and Tesla, rising oil prices, and higher bond yields, many investors are looking past high growth s...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.